Prenetics

Prenetics

Prenetics is a leading health sciences company dedicated to advancing consumer and clinical health.

Founded 2014

Hong Kong S.a.r. 215 employees Post-IPO Equity Total: $187.65M Biotechnology, Health Care +1

Prenetics is a genomics-driven health sciences company with a mission to decentralize healthcare through testing covering prevention, diagnostics, and personalized care. Established in 2009 and headquartered in Hong Kong S.a.r., the company has received a significant $120.00M Post-IPO Equity investment at 18 May 2022 from notable investors such as Aspex Management, PAG, Xen Capital, Dragonstone, and Lippo Group. Prenetics' operations are segmented into multiple arms, each focusing on different aspects of healthcare. CircleDNA, the prevention arm, offers comprehensive consumer DNA testing using whole exome sequencing. In collaboration with Prof. Dennis Lo, Insighta, their joint venture worth $200 million, concentrates on pioneering multi-cancer early detection technologies. Additionally, their treatment unit, ACT Genomics, stands as the first Asia-based company to achieve FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. Prenetics' innovative approach towards prevention, early detection, and treatment, coupled with significant financial support from investors, reaffirms the company's commitment to 'enhancing life through science.' With a focus on biotechnology, healthcare, and insurtech industries, Prenetics is well-positioned to make a substantial global impact on health through its synergistic units.

Funding Stage	Amount	Investors	Lead Investors	Date
Post IPO Equity	$120.00M	5	Aspex Management, PAG +3	18 May 2022
Venture Round	Undisclosed	1	500 Startups	04 May 2021
Private Equity Round	$15.00M	2	Alibaba Entrepreneurs Fund, Apis Partners	17 Sep 2020
Series B	$40.00M	4	Beyond Ventures, Alibaba Entrepreneurs Fund +2	17 Oct 2017
Series A	$10.00M	5	500 Startups, Capital Union Investments +3	16 Mar 2016
Series A	$2.65M	5	500 Startups, Capital Union Investments +3	03 Dec 2014

Funding Stage

Amount

Investors

Lead Investors

Date

Post IPO Equity

$120.00M

Aspex Management, PAG +3

18 May 2022

Venture Round

Undisclosed

500 Startups

04 May 2021

Private Equity Round

$15.00M

Alibaba Entrepreneurs Fund, Apis Partners

17 Sep 2020

Series B

$40.00M

Beyond Ventures, Alibaba Entrepreneurs Fund +2

17 Oct 2017

Series A

$10.00M

500 Startups, Capital Union Investments +3

16 Mar 2016

Series A

$2.65M

500 Startups, Capital Union Investments +3

03 Dec 2014

FAQ About Prenetics

Prenetics is a leading health sciences company dedicated to advancing consumer and clinical health.

Prenetics was founded in 2014.

Prenetics is headquartered in Hong Kong S.a.r..

Prenetics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on genomics-driven health sciences, DNA testing, early detection and cancer screening.

Prenetics has approximately 215 employees.

Prenetics has completed 6 funding rounds, raising a total of $187.65M. The latest funding stage is Post-IPO Equity.

Top alternatives and competitors to Prenetics include Lucence, Cleveland Diagnostics, Singlera Genomics Incorporated, Beacon Biomedical, ACT Genomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Prenetics and Lucence are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Prenetics

Funding Rounds & Investors (6)

Prenetics Alternatives & Competitors

FAQ About Prenetics